ProfileGDS5678 / 1446735_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 5% 6% 6% 7% 12% 5% 5% 42% 6% 6% 6% 17% 6% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.07165
GSM967853U87-EV human glioblastoma xenograft - Control 22.11126
GSM967854U87-EV human glioblastoma xenograft - Control 32.104066
GSM967855U87-EV human glioblastoma xenograft - Control 42.128177
GSM967856U87-EV human glioblastoma xenograft - Control 52.2593812
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.105995
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.072985
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9534942
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.073226
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.09986
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.096916
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.380717
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.101596
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.099536